LSIPR 50 2018: At the head of an experiment in innovation
Marie-Paule Kieny of the Drugs for Neglected Diseases Initiative is on a mission to remind stakeholders and governments that there is a moral imperative to pursue the fight against neglected diseases, as she tells LSIPR.
LSIPR 50 2018: A decade in the making, a Parkinson’s breakthrough
A team at the University of Dundee has announced a major breakthrough in the understanding of Parkinson’s disease. LSIPR heard more from Miratul Muqit and Daan van Aalten of the university’s school of life sciences.
LSIPR 50 2018: Dreaming big to fight HIV
Glenda Gray, CEO and president of the South African Medical Research Council, tells LSIPR of the life-saving work she is undertaking and her ambitious goals to improve the South African healthcare landscape.
LSIPR 50 2018: It’s not like selling cars
Balancing a company’s duty to shareholders with the public responsibility to provide lifesaving treatments is a constant challenge, as Issi Rozen, chief business officer at the Broad Institute of MIT and Harvard, tells LSIPR.
LSIPR 50 2018: Big changes in Brazil
With his interests in IP development, biotechnology innovation policy, and R&D, Luiz Otávio Pimentel, president of Brazil’s patent office, tells LSIPR of his aims to improve the country’s IP performance.
LSIPR 50 2018: Uniting the IP chorus
Brexit has created many uncertainties in the IP arena and the CEO of the UK Intellectual Property Office is urging stakeholders to speak up, so that the office isn’t the “lone voice” advocating the importance of IP.
LSIPR 50 2018: Levelling the medicines playing field
Speaking to LSIPR Leena Menghaney, regional head of Médecins Sans Frontières’ Access Campaign in South Asia, explains the importance of a balanced IP policy in fostering healthy generic competition.
Investing in patent search: tips for practitioners
In order to maximise the value from the patent search process, IP practitioners should take note of several tips including offering clear guidance to the searcher—and even saying ‘thank you’. Ellen Sherin of GQ Life Sciences reports.
The future of precision medicine part 1: challenges and opportunities
The healthcare industry and governments around the world are turning to precision medicine as an opportunity and a potential saviour. Daniel Lim of Kirkland & Ellis discusses the issues around translating the promise of precision medicine into real world clinical practice.
Conference preview: International Pharma Patent Term Extensions Forum
C5’s International Pharma Patent Term Extensions Forum, which will be held in Munich, Germany on June 19 and 20, will provide guidance on patent term extensions in the world’s key IP regions, as LSIPR finds out.
